About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Artm1Verh
targeted mutation 1, Guido Verhoeven
MGI:3034098
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Artm1Verh/Y
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2 MGI:5009703
cn2
Artm1Verh/Y
Plekha5Tg(AMH-cre)1Flor/Plekha5+
involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 MGI:3036125
cn3
Artm1Verh/Y
Tg(Fabp4-cre)1Rev/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 MGI:5502687
cn4
Artm1Verh/Y
Rnase10tm1(cre)Hht/Rnase10+
involves: 129S7/SvEvBrd * C57BL/6 MGI:5051914
ot5
Artm1Verh/Y involves: 129S1/Sv * 129X1/SvJ MGI:3036137


Genotype
MGI:5009703
cn1
Allelic
Composition
Artm1Verh/Y
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
Genetic
Background
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Artm1Verh mutation (1 available); any Ar mutation (22 available)
Ptentm1Hwu mutation (16 available); any Pten mutation (81 available)
Tg(Pbsn-cre)4Prb mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• mutants develop adenocarcinoma in the dorsolateral lobes of the prostate
• cancer progression is similar to single conditional Pten mice
• proliferation and apoptotic indexes are increased in the cancers, most notably in the proximal regions of the dorsal-lateral lobe
• mutant tumors contain low or no p63+ cells, similar to human prostate cancer
• castrated mutants develop cancer outgrowths in the dorsolateral lobes, indicating that mutants develop castrate-resistant prostate cancer
• castrated mice treated with rapamycin show a reduction in prostate volume and reduced prostate proliferation

reproductive system
• mutants develop adenocarcinoma in the dorsolateral lobes of the prostate
• cancer progression is similar to single conditional Pten mice
• proliferation and apoptotic indexes are increased in the cancers, most notably in the proximal regions of the dorsal-lateral lobe
• mutant tumors contain low or no p63+ cells, similar to human prostate cancer
• castrated mutants develop cancer outgrowths in the dorsolateral lobes, indicating that mutants develop castrate-resistant prostate cancer
• castrated mice treated with rapamycin show a reduction in prostate volume and reduced prostate proliferation

endocrine/exocrine glands
• mutants develop adenocarcinoma in the dorsolateral lobes of the prostate
• cancer progression is similar to single conditional Pten mice
• proliferation and apoptotic indexes are increased in the cancers, most notably in the proximal regions of the dorsal-lateral lobe
• mutant tumors contain low or no p63+ cells, similar to human prostate cancer
• castrated mutants develop cancer outgrowths in the dorsolateral lobes, indicating that mutants develop castrate-resistant prostate cancer
• castrated mice treated with rapamycin show a reduction in prostate volume and reduced prostate proliferation




Genotype
MGI:3036125
cn2
Allelic
Composition
Artm1Verh/Y
Plekha5Tg(AMH-cre)1Flor/Plekha5+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Artm1Verh mutation (1 available); any Ar mutation (22 available)
Plekha5Tg(AMH-cre)1Flor mutation (1 available); any Plekha5 mutation (109 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• at P50, numbers of round spermatids were reduced to only 3% of wild-type numbers
• the few round spermatids that formed appeared abnormal and failed to survive beyond stages VII-VIII
• no elongated spermatids were detected
• at P50, numbers of diplotene and secondary spermatocytes were reduced to 64% of wild-type numbers
• reduced germ cell numbers associated with increased apoptosis
• absence of elongated spermatids
• at P50, reduced male germ cell numbers were associated with a 4-5-fold increase in germ cell apoptosis
• significant reduction in seminiferous tubule diameter at P50
• however, numbers of Sertoli cells remained essentially normal based on measurement of nuclear volume per testis
• as expected, Leydig cell cytoplasmic volume was relatively constant up to P20 and more than doubled between P20 and P50; however, an additional 32% increase occurred between P50 and P140, such that at P140 cytoplasmic volume was 23% higher than that in controls
• at P50, the volumes of mitochondria and lipid droplets were 2-fold higher than in controls; however, only the increase in lipid droplets was statistically significant
• although Leydig cell number was normal at P12, it was reduced by >40% at later ages (P20, P50, and P140)
• notably, the temporal pattern of change in LC number was generally similar to that of controls
• at P50 and P140, LC number was significantly higher than in Artm1.1Verh males
• immunohistochemistry and quantitative PCR for LC-specific markers revealed that steroidogenic function per LC was probably increased
• testes were properly descended but small in size
• normal development of epididymis, vas deferens, coagulating gland, seminal gland, and prostate gland
• normal development of Leydig cells and peritubular myoid cells
• at P50, testis weight was reduced to 28.4% of wild-type weight (J:88169)
• although normal at P12, testis weight was reduced to 53% of control value at P20 and to 25-30% of control value at P50 and P140 (J:100799)
• spermatogenic arrest at the late spermatocyte/spermatid stage
• normal entry into meiosis, but progressive loss of pachytene primary spermatocytes between stages VI and XII
• at P50, epididymis weight was reduced by 30% relative to wild-type

homeostasis/metabolism
• at P50, serum FSH leves were elevated by 34% relative to wild-type
• in contrast, serum levels of testosterone and luteinizing hormone remained normal

endocrine/exocrine glands
• significant reduction in seminiferous tubule diameter at P50
• however, numbers of Sertoli cells remained essentially normal based on measurement of nuclear volume per testis
• as expected, Leydig cell cytoplasmic volume was relatively constant up to P20 and more than doubled between P20 and P50; however, an additional 32% increase occurred between P50 and P140, such that at P140 cytoplasmic volume was 23% higher than that in controls
• at P50, the volumes of mitochondria and lipid droplets were 2-fold higher than in controls; however, only the increase in lipid droplets was statistically significant
• although Leydig cell number was normal at P12, it was reduced by >40% at later ages (P20, P50, and P140)
• notably, the temporal pattern of change in LC number was generally similar to that of controls
• at P50 and P140, LC number was significantly higher than in Artm1.1Verh males
• immunohistochemistry and quantitative PCR for LC-specific markers revealed that steroidogenic function per LC was probably increased
• testes were properly descended but small in size
• normal development of epididymis, vas deferens, coagulating gland, seminal gland, and prostate gland
• normal development of Leydig cells and peritubular myoid cells
• at P50, testis weight was reduced to 28.4% of wild-type weight (J:88169)
• although normal at P12, testis weight was reduced to 53% of control value at P20 and to 25-30% of control value at P50 and P140 (J:100799)

growth/size/body
N
• growth curves of hemizygous mutant males were similar to those of wild-type males

cellular
• at P50, numbers of round spermatids were reduced to only 3% of wild-type numbers
• the few round spermatids that formed appeared abnormal and failed to survive beyond stages VII-VIII
• no elongated spermatids were detected
• at P50, numbers of diplotene and secondary spermatocytes were reduced to 64% of wild-type numbers
• reduced germ cell numbers associated with increased apoptosis
• absence of elongated spermatids
• normal entry into meiosis, but progressive loss of pachytene primary spermatocytes between stages VI and XII
• at P50, reduced male germ cell numbers were associated with a 4-5-fold increase in germ cell apoptosis




Genotype
MGI:5502687
cn3
Allelic
Composition
Artm1Verh/Y
Tg(Fabp4-cre)1Rev/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Artm1Verh mutation (1 available); any Ar mutation (22 available)
Tg(Fabp4-cre)1Rev mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
adipose tissue
• while males on a normal chow diet are not obese, they show reduced perigonadal fat weight but increased interscapular brown adipose tissue at 3 months age
• however, body fat composition is no longer different by 6 months of age
• on a high-fat diet, males gain equal weight compared with controls, however after 24 weeks, they have more visceral fat, with increases in omental and mesenteric fat pad weights
• on a normal chow diet, males have an increase in interscapular brown adipose tissue at 3 months of age
• however, white adipose tissue morphology in the perigonadal and subcutaneous depots are normal
• on a normal chow diet, males have reduced perigonadal fat weight and proportion
• after 24 weeks of a high-fat diet, males show an increase in mesenteric fat pad weight compared to controls
• after 24 weeks of a high-fat diet, males show an increase in omental fat pad weight compared to controls
• on a normal chow diet, males have an increase in interscapular brown adipose tissue at 3 months of age

growth/size/body
• on a normal chow diet, males gain less weight than controls at 3 months of age

homeostasis/metabolism
• males are euglycemic at 3 months of age, however between 3 and 12 months of age, males are unable to sustain the normal increase in insulin secretory capacity, and they develop hyperglycemia
• after 24 weeks on a high-fat diet, mutants have a poorer secretory response and become more hyperglycemic than controls
• males are euglycemic but hyperinsulinemic both in the fasted state and during glucose tolerance testing at 3 months of age
• 3 month old males have elevated plasma triglyceride levels but normal liver triglycerides
• males show age-related glucose intolerance
• insulin resistance in 3 month old males on a normal diet, as indicated by hyperinsulinemia both in the fasted state and during glucose tolerance




Genotype
MGI:5051914
cn4
Allelic
Composition
Artm1Verh/Y
Rnase10tm1(cre)Hht/Rnase10+
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Artm1Verh mutation (1 available); any Ar mutation (22 available)
Rnase10tm1(cre)Hht mutation (0 available); any Rnase10 mutation (13 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• undergoing degeneration at 4 months
• germinal epithelium lost in many tubules
• intraepithelial cysts frequently found
• at four months
• as a result of fluid retention
• spermatic granulomata frequently obstruct the epididymes
• initial segment hypoplasia by 30 days
• epididymis becomes obstructed at the level of the caput
• sperm build-up starting around 40 days causes severe dilation and finally, complete occlusion
• decreased height after 20-25 days in segments I and II
• begins to degenerate distal to occlusion
• some males develop unilateral orchitis
• no pregnancies after mating to CD1 females
• vaginal plugs are produced

endocrine/exocrine glands
• undergoing degeneration at 4 months
• germinal epithelium lost in many tubules
• intraepithelial cysts frequently found
• at four months
• as a result of fluid retention
• some males develop unilateral orchitis

immune system
• some males develop unilateral orchitis




Genotype
MGI:3036137
ot5
Allelic
Composition
Artm1Verh/Y
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Artm1Verh mutation (1 available); any Ar mutation (22 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
N
• genotypic males had a male phenotype and showed normal development of the male urogenital system





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory